DexCom Inc.
Cash Flow Statement
| Line Item | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $-50.2M | $-65.6M | $-57.6M | $-22.4M | $-29.8M | $-54.5M | $-44.7M | $-55.2M |
| Depreciation & Amortization | $16.1M | $15.0M | $10.8M | $8.4M | $7.0M | $6.6M | $3.8M | $2.4M |
| Depreciation | $16.1M | $14.4M | $10.2M | $7.8M | $6.4M | $6.1M | $3.8M | — |
| Amortization | — | $700.0K | $500.0K | $600.0K | $600.0K | $500.0K | — | — |
| Stock-Based Compensation | $106.2M | $110.8M | $82.7M | $50.0M | $24.6M | $18.4M | $13.5M | $9.4M |
| Net Cash from Operating Activities | $92.0M | $56.2M | $49.0M | $23.6M | $2.4M | $-33.1M | $-30.1M | $-42.7M |
| Investing Activities | ||||||||
| Capital Expenditures | $66.0M | $55.7M | $33.3M | $16.2M | $7.9M | $9.5M | $8.0M | $6.9M |
| Business Acquisitions | $0 | $-300.0K | $500.0K | $0 | $0 | — | — | — |
| Net Cash from Investing Activities | $-144.4M | $-55.9M | $-51.5M | $-16.8M | $20.9M | $28.4M | $-46.4M | $-25.6M |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | $0 | $0 | — | — | — | — | — | — |
| Net Cash from Financing Activities | $399.1M | $8.1M | $16.8M | $21.8M | $11.8M | $10.2M | $74.2M | $69.6M |
| Net Change in Cash | $347.0M | $8.4M | $14.3M | $28.6M | $35.1M | $5.5M | $-2.3M | $1.3M |
| Free Cash Flow | $26.0M | $500.0K | $15.7M | $7.4M | $-5.5M | $-42.6M | $-38.1M | $-49.6M |